• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Respir J . Metabolomic analyses reveals new stage-specific features of the COVID-19

tetano

Editor, Senior Moderator
Eur Respir J


. 2021 Jul 21;2100284.
doi: 10.1183/13993003.00284-2021. Online ahead of print.
Metabolomic analyses reveals new stage-specific features of the COVID-19


Hongling Jia[SUP] 1 2 3 [/SUP], Chaowu Liu[SUP] 4 3 [/SUP], Dantong Li[SUP] 5 3 [/SUP], Qingsheng Huang[SUP] 6 3 [/SUP], Dong Liu[SUP] 7 3 [/SUP], Ying Zhang[SUP] 1 3 [/SUP], Chang Ye[SUP] 6 [/SUP], Di Zhou[SUP] 8 [/SUP], Yang Wang[SUP] 8 [/SUP], Yanlian Tan[SUP] 2 [/SUP], Kuibiao Li[SUP] 1 [/SUP], Fangqin Lin[SUP] 6 [/SUP], Haiqing Zhang[SUP] 9 [/SUP], Jingchao Lin[SUP] 8 [/SUP], Yang Xu[SUP] 1 [/SUP], Jingwen Liu[SUP] 1 [/SUP], Qing Zeng[SUP] 1 [/SUP], Jian Hong[SUP] 10 [/SUP], Guobing Chen[SUP] 11 [/SUP], Hao Zhang[SUP] 12 [/SUP], Lingling Zheng[SUP] 6 [/SUP], Xilong Deng[SUP] 13 [/SUP], Changwen Ke[SUP] 14 [/SUP], Yunfei Gao[SUP] 15 16 [/SUP], Jun Fan[SUP] 2 [/SUP], Biao Di[SUP] 1 [/SUP], Huiying Liang[SUP] 5 17 [/SUP]



Affiliations

Abstract

The current pandemic of coronavirus disease 19 (COVID-19) has affected more than 160 million of individuals and caused millions of deaths worldwide at least in part due to the unclarified pathophysiology of this disease. Therefore, identifying the underlying molecular mechanisms of COVID-19 is critical to overcome this pandemic. Metabolites mirror the disease progression of an individual by acquiring extensive insights into the pathophysiological significance during disease progression. We provide a comprehensive view of metabolic characterization of sera from COVID-19 patients at all stages using untargeted and targeted metabolomic analysis. As compared with the healthy controls, we observed different alteration patterns of circulating metabolites from the mild, severe and recovery stages, in both discovery cohort and validation cohort, which suggest that metabolic reprogramming of glucose metabolism and urea cycle are potential pathological mechanisms for COVID-19 progression. Our findings suggest that targeting glucose metabolism and urea cycle may be a viable approach to fight against COVID-19 at various stages along the disease course.
 
Back
Top Bottom